Your browser doesn't support javascript.
loading
A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy.
Jeon, Eun-Seok; Lim, Sang Wook; Kim, Seok-Yeon; Yang, Hyoung-Mo; Kim, Moo Hyun; Rhee, Moo-Yong; Han, Seung Hwan; Shin, Jinho; Kim, Kwang-Il; Jeong, Jin-Ok; Sung, Ki Chul; Hong, Geu Ru; Kim, Hyung-Seop; Kwon, Kihwan; Kang, Tae-Soo; Lee, Hae-Young; Han, Su-Eun.
Afiliación
  • Jeon ES; Division of Cardiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Lim SW; Division of Cardiology, Bundang Cha Hospital, Cha University, Seongnam, Republic of Korea.
  • Kim SY; Department of Cardiology, Cardiovascular Center, Seoul Medical Center, Seoul, Republic of Korea.
  • Yang HM; Division of Cardiology, Ajou University Hospital, Suwon, Republic of Korea.
  • Kim MH; Department of Cardiology, Dong-A University Hospital, Busan, Republic of Korea.
  • Rhee MY; Cardiovascular Center, Dongguk University Ilsan Hospital, Goyang, Republic of Korea.
  • Han SH; Division of Cardiology, Gachon University Gil Medical Center, Incheon, Republic of Korea.
  • Shin J; Department of Internal Medicine, Hanyang University Hospital, Seoul, Republic of Korea.
  • Kim KI; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Jeong JO; Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea.
  • Sung KC; Division of Cardiology, Kangbuk Samsung Hospital, Seoul, Republic of Korea.
  • Hong GR; Division of Cardiology, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Kim HS; Department of Internal Medicine, Dongsan Medical Center, Keimyung University, Deagu, Republic of Korea.
  • Kwon K; Division of Cardiology, Ewha Womans University College of Medicine, Seoul, Republic of Korea.
  • Kang TS; Division of Cardiology, Dankook Unversity Hospital, Cheonan, Republic of Korea.
  • Lee HY; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Han SE; Clinical Strategy Department, Boryung Corporation, 136 Changgyeonggung-ro, Jongno-gu, Seoul, Republic of Korea. sehan83@boryung.co.kr.
Clin Hypertens ; 28(1): 40, 2022 Dec 01.
Article en En | MEDLINE | ID: mdl-36451242
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Clin Hypertens Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Clin Hypertens Año: 2022 Tipo del documento: Article